OB/GYN News

FDA approves drug for late-stage and aggressive cervical cancer

Avastin (bevacizumab) has been approved to treat patients with persistent, recurrent, or metastatic cervical cancer by the US Food and Drug Administration (FDA). » Read

HAVE YOU READ THESE?

› Investigational fertility treatment approved by FDA

› FDA prepares to approve Perjeta

POLL

Tell us: Has your facility issued an official policy on morcellation?

› Yes
› No

Click to contact the Editorial Team
Click to contact the Sales Team (Reprints, Classifieds)